Future Health ESG Change in Accounts Receivable 2022-2023 | FHLT
Future Health ESG change in accounts receivable from 2022 to 2023. Change in accounts receivable can be defined as the increase or decrease in accounts receivable for the given period.
| Future Health ESG Annual Change in Accounts Receivable (Millions of US $) |
|
|---|---|
| 2023 | $N/A |
| 2022 | $N/A |
| 2021 | $N/A |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.000B | $0.000B |
| Future Health ESG Corp. entered into a definitive business combination agreement with Excelera DCE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.128B | 58.69 |
| Hims & Hers Health (HIMS) | United States | $11.646B | 121.00 |
| Doximity (DOCS) | United States | $11.561B | 53.52 |
| Tempus AI (TEM) | United States | $10.010B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.435B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.739B | 0.00 |
| Privia Health (PRVA) | United States | $2.547B | 174.08 |
| Enovis (ENOV) | United States | $1.826B | 10.18 |
| Phreesia (PHR) | United States | $1.642B | 0.00 |
| Schrodinger (SDGR) | United States | $1.551B | 0.00 |
| 10x Genomics (TXG) | United States | $1.535B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.527B | 0.00 |
| Azenta (AZTA) | United States | $1.475B | 68.57 |
| Evolent Health (EVH) | United States | $1.334B | 113.60 |
| Omnicell (OMCL) | United States | $1.291B | 22.78 |
| Claritev (CTEV) | United States | $0.763B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.582B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.475B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.450B | 0.00 |
| Talkspace (TALK) | United States | $0.430B | 128.50 |
| Outset Medical (OM) | United States | $0.333B | 0.00 |
| TruBridge (TBRG) | United States | $0.329B | 731.00 |
| Health Catalyst (HCAT) | United States | $0.269B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.267B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.231B | 0.00 |
| CapsoVision (CV) | United States | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.149B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.139B | 0.00 |
| American Well (AMWL) | United States | $0.126B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.122B | 0.00 |
| Pulmonx (LUNG) | United States | $0.108B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.098B | 3.73 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.091B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |